Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | FAAH | O00519 | 4/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.37 |
| ▸ | F7 | P08709 | 1/20 | 0.36 |
| ▸ | F3 | P13726 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8070636 | 0.75 | MGLL (0.36) | MGLLTSHRFAAHALDH1A1ALOX15 | |
| SCHEMBL8070629 | 0.75 | MGLL (0.36) | MGLLTSHRFAAHALDH1A1ALOX15 | |
| SCHEMBL25392801 | 0.74 | CYP3A4 (0.48) | MGLLTSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL5815289 | 0.72 | FAAH (0.38) | MGLLTSHRFAAHTRPV1F7 | |
| SCHEMBL5815286 | 0.72 | FAAH (0.38) | MGLLTSHRFAAHTRPV1F7 | |
| SCHEMBL5802377 | 0.70 | FAAH (0.42) | MGLLTSHRFAAHTRPV1F7 | |
| SCHEMBL3307530 | 0.68 | TSHR (0.39) | TSHRFAAHTRPV1F7F3 | |
| SCHEMBL9870660 | 0.68 | TSHR (0.39) | TSHRFAAHTRPV1F7F3 | |
| SCHEMBL93117 | 0.68 | FAAH (0.55) | TSHRFAAHTRPV1F7F3 | |
| SCHEMBL17262056 | 0.68 | FAAH (0.55) | TSHRFAAHTRPV1F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2380928-B1 | TRISALKENYL(ISO)CYANURATE CROSS LINKING AGENTS AND PROCESS FOR PRODUCING CROSSLINKED ORGANIC POLYMERS | EVONIK DEGUSSA GMBH (DE) | 2018-05-30 | — | — | EP | claimed |
| US-20240076429-A1 | CONDUCTIVE FLUORINATED ELASTOMERIC MATERIALS AND METHODS OF USE | META PLATFORMS TECHNOLOGIES, LLC | 2024-03-07 | — | — | US | disclosed |
| CN-109937508-B | Nonaqueous electrolyte secondary battery | 松下知识产权经营株式会社 | 2023-04-21 | — | — | CN | disclosed |
| US-10991981-B2 | Nonaqueous electrolyte secondary battery | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2021-04-27 | — | — | US | disclosed |
| US-20210020990-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2021-01-21 | — | — | US | disclosed |
| EP-3761434-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | Panasonic Intellectual Property Management Co., Ltd. (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20190326640-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| EP-3094685-A1 | CURABLE COMPOSITION FOR OPTICAL SEMICONDUCTOR DEVICES | Henkel AG & Co. KGaA (DE) | 2016-11-23 | — | — | EP | disclosed |
| US-20160319103-A1 | CURABLE COMPOSITION FOR OPTICAL SEMICONDUCTOR DEVICES | HENKEL AG & CO KGAA (DE) | 2016-11-03 | — | — | US | disclosed |
| CN-102234378-B | Produce the method for crosslinked organic polymer | EVONIK DEGUSSA GMBH (DE) | 2015-11-25 | — | — | CN | disclosed |
| WO-2015106438-A1 | CURABLE COMPOSITION FOR OPTICAL SEMICONDUCTOR DEVICES | HENKEL (CHINA) COMPANY LIMITED (CN) | 2015-07-23 | — | — | WO | disclosed |
| CN-102234378-A | Process for producing crosslinked organic polymers | EVONIK DEGUSSA GMBH | 2011-11-09 | — | — | CN | disclosed |
| US-20110263748-A1 | PROCESS FOR PRODUCING CROSSLINKED ORGANIC POLYMERS | EVONIK DEGUSSA GMBH (DE) | 2011-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10991981-B2 | Nonaqueous electrolyte secondary battery | CA9, CA1, CA13 | MGLL 3530/4885TSHR 3355/4885FAAH 1878/4885 |
| US-20190326640-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | CA9, CA1, CA13 | MGLL 3530/4885TSHR 3355/4885FAAH 1878/4885 |
| US-20210020990-A1 | NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | CA1, CA9, CA3 | MGLL 4688/4885TSHR 4133/4885FAAH 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.